You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (1) |
Back to Search
Regulate patients's use of medicinal herb during cancer chemotherapy: VigiBase,WHO global database survey
- At: Virtual 2020 (2020)
- Type: Poster
- Poster code: POS-PPR-041
- By: LECHON, Anne-Sophie (Université Libre de Bruxelles (ULB), Department of Pharmacotherapy and pharmaceutics, Faculty of Pharmacy, Belgium)
- Co-author(s): Anne-Sophie Lechon: Department of Pharmacotherapy and pharmaceutics, Faculty of Pharmacy, Université Libre de Bruxelles (ULB), Brussels, Belgium
Véronique Mathieu: Department of Pharmacotherapy and pharmaceutics, Faculty of Pharmacy, Université Libre de Bruxelles (ULB), Brussels, Belgium
Carine De Vriese: Department of Pharmacotherapy and pharmaceutics, Faculty of Pharmacy, Université Libre de Bruxelles (ULB), Brussels, Belgium
Stéphanie Pochet: Department of Pharmacotherapy and pharmaceutics, Faculty of Pharmacy, Université Libre de Bruxelles (ULB), Brussels, Belgium
Jamila Hamdani: Belgian Center for Pharmacovigilance (BCPH), Federal Agency Federal Agency for Medicines and Health Products (FAMHP), Brussels, Belgium
Cécile Lescrainier: Belgian Center for Pharmacovigilance (BCPH), Federal Agency Federal Agency for Medicines and Health Products (FAMHP), Brussels, Belgium
Florence Souard: Department of Pharmacotherapy and pharmaceutics, Faculty of Pharmacy, Université Libre de Bruxelles (ULB), Brussels, Belgium - Abstract:
Background
Up to 70 % of cancer patients use Herbal Medicines (HMs)1 while there is a risk of interactions with Anti Cancer Drugs (ACDs).
Purpose
The aim of this study was to analyse the adverse effects suspected to be associated with the concomitant use of a plant and a drug using Individual Case Safety Reports (ICSRs) from the World Health
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026